MXPA04001526A - Composiciones de polipetidos kgf. - Google Patents

Composiciones de polipetidos kgf.

Info

Publication number
MXPA04001526A
MXPA04001526A MXPA04001526A MXPA04001526A MXPA04001526A MX PA04001526 A MXPA04001526 A MX PA04001526A MX PA04001526 A MXPA04001526 A MX PA04001526A MX PA04001526 A MXPA04001526 A MX PA04001526A MX PA04001526 A MXPA04001526 A MX PA04001526A
Authority
MX
Mexico
Prior art keywords
kgf
polypeptides
polypeptide compositions
compositions
kgf polypeptide
Prior art date
Application number
MXPA04001526A
Other languages
English (en)
Spanish (es)
Inventor
J Gospodarowicz Denis
Original Assignee
Chiron Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=23217561&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=MXPA04001526(A) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Chiron Corp filed Critical Chiron Corp
Publication of MXPA04001526A publication Critical patent/MXPA04001526A/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/475—Growth factors; Growth regulators
    • C07K14/50—Fibroblast growth factor [FGF]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/18—Growth factors; Growth regulators
    • A61K38/1825—Fibroblast growth factor [FGF]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Engineering & Computer Science (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Zoology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biophysics (AREA)
  • Toxicology (AREA)
  • Biochemistry (AREA)
  • Dermatology (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Immunology (AREA)
  • Epidemiology (AREA)
  • Ophthalmology & Optometry (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
MXPA04001526A 2001-08-21 2002-08-21 Composiciones de polipetidos kgf. MXPA04001526A (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US31388101P 2001-08-21 2001-08-21
PCT/US2002/026929 WO2003016505A2 (en) 2001-08-21 2002-08-21 Kgf polypeptide compositions

Publications (1)

Publication Number Publication Date
MXPA04001526A true MXPA04001526A (es) 2004-05-31

Family

ID=23217561

Family Applications (1)

Application Number Title Priority Date Filing Date
MXPA04001526A MXPA04001526A (es) 2001-08-21 2002-08-21 Composiciones de polipetidos kgf.

Country Status (8)

Country Link
US (2) US7265089B2 (cg-RX-API-DMAC7.html)
EP (1) EP1429799A4 (cg-RX-API-DMAC7.html)
JP (2) JP2005500390A (cg-RX-API-DMAC7.html)
AU (1) AU2002326742B2 (cg-RX-API-DMAC7.html)
CA (1) CA2457781A1 (cg-RX-API-DMAC7.html)
MX (1) MXPA04001526A (cg-RX-API-DMAC7.html)
PL (1) PL374269A1 (cg-RX-API-DMAC7.html)
WO (1) WO2003016505A2 (cg-RX-API-DMAC7.html)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BR112012000865A2 (pt) * 2009-07-17 2019-09-24 T Tabor Aaron "composição e método para a modificação genética cosmética de células substancialmente intactas"
US20160250298A1 (en) 2013-11-01 2016-09-01 Spherium Biomed S.L. Inclusion bodies for transdermal delivery of therapeutic and cosmetic agents
TW201613622A (en) * 2014-10-14 2016-04-16 Bionet Corp Composition for skincare and pharmaceutical composition and preparation method thereof
CN109402130A (zh) * 2018-11-23 2019-03-01 成都中医药大学附属医院 一种重组人角质细胞生长因子-1及其制备方法和用途
KR20230127721A (ko) * 2022-02-25 2023-09-01 한국해양과학기술원 온도안정성을 향상시킨 fgf7 폴리펩타이드 및 그 용도

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DK0555205T3 (da) 1989-01-31 2001-03-05 Jeffrey S Rubin DNA, der koder for en væstfaktor, som er specifik for epitelceller
US5194596A (en) 1989-07-27 1993-03-16 California Biotechnology Inc. Production of vascular endothelial cell growth factor
US5350836A (en) 1989-10-12 1994-09-27 Ohio University Growth hormone antagonists
US5655870A (en) * 1993-03-01 1997-08-12 Kawasaki Steel Corporation Stacker crane in a warehouse
US5814605A (en) 1993-03-26 1998-09-29 Amgen Inc. Therapeutic uses of keratinocyte growth factor
NZ266622A (en) 1993-06-29 1997-10-24 Chiron Corp Keratinocyte growth factor fragment (kgf) with at least a 2-fold increase in mitogenic activity compared to a full length kgf; dna molecules, expression vectors, host cells, and conjugates
SI0785950T1 (en) 1994-10-13 2003-08-31 Amgen Inc. Keratinocyte growth factor analogs
EP0804479B1 (en) * 1994-10-13 2006-10-11 Amgen Inc., Method of treating diabetes mellitus using kgf
DK0785949T3 (da) * 1994-10-13 2003-08-18 Amgen Inc Fremgangsmåde til oprensning af keratinocytvækstfaktorer
US5841605A (en) * 1996-11-06 1998-11-24 Iomega Corporation Caddy for cartridge and disk drive accomodating a caddy
ES2181054T3 (es) * 1996-12-06 2003-02-16 Amgen Inc Utilizacion de producto(s) proteico(s) kgf y de producto(s) proteico(s) glp-2 para la preparacion de un medicamento.

Also Published As

Publication number Publication date
CA2457781A1 (en) 2003-02-27
JP2009221207A (ja) 2009-10-01
JP2005500390A (ja) 2005-01-06
US7265089B2 (en) 2007-09-04
PL374269A1 (en) 2005-10-03
WO2003016505A2 (en) 2003-02-27
US20080200378A1 (en) 2008-08-21
EP1429799A4 (en) 2005-12-21
US20030109439A1 (en) 2003-06-12
WO2003016505A3 (en) 2004-01-08
EP1429799A2 (en) 2004-06-23
AU2002326742B2 (en) 2007-05-31

Similar Documents

Publication Publication Date Title
ATE293159T1 (de) Stabilisierendes verdünnungsmittel für polypeptide und antigene
WO2002020767A3 (en) G-csf analog compositions and methods
EP2298354A3 (en) Remodelling and glycoconjugation of interferon-beta
IL142350A0 (en) Interferon-beta fusion proteins and pharmaceutical compositions containing the same
MY137181A (en) Pulmonary administration of chemically modified insulin
TW200611910A (en) Interferon-alpha polypeptides and conjugates
WO1998033509A3 (en) Useful properties of human lactoferrin and variants thereof
DE69823046D1 (de) Praktische in vitro sialylierung von rekombinanten glykpproteinen
HUE038162T2 (hu) Stabilizált VII faktor polipeptid készítmények
WO2003010288A3 (en) Yeast expression systems, methods of producing polypeptides in yeast, and compositions relating to same
MXPA02004666A (es) Gelatinas recombinantes.
AU4162400A (en) Derivatives of the b or z domain from staphylococcal protein a (spa) interactingwith at least one domain of human factor viii
DK1356052T3 (da) Produktion af hele antistoffer i prokaryotiske celler
WO1999045098A3 (en) Delivery or proteins into eukaryotic cells with recombinant yersinia
TWI317736B (en) Methods for the production of redox proteins and heteromultimeric-protein-complexes, and related compositions related applications
AU2002310321A8 (en) Compositions and methods for high-level, large-scale production of recombinant proteins
WO2004046365A3 (en) Interferon-alpha polypeptides and conjugates
SG158141A1 (en) Pancreatic polypeptide family motifs, polypeptides and methods comprising the same
AU2002232819A1 (en) Methods for the production of multimeric proteins, and related compositions
MXPA03010684A (es) Peptidos y el uso de los mismos para oscurecer la piel.
CA2388910A1 (en) Antimicrobial activity of the first cationic cluster of human lactoferrin
WO2005035570A3 (en) Variants of cd40l protein
MXPA04001252A (es) Nuevos heterociclos benzo-fusionados como antagonistas de endotelina.
WO2003016505A3 (en) Kgf polypeptide compositions
MXPA03010683A (es) Composicion que contiene un peptido y un pigmento y el uso del mismo para oscurecer la piel.

Legal Events

Date Code Title Description
HC Change of company name or juridical status
FG Grant or registration